The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Nutrition and ExerciseNutrition and Exercise
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

update on Ibalizumab
Apr 19, 2012

I have now been luck enough to add this drug as well as others to provide a working "cocktail".....As of my last lab, I was undetectable for the first time in 20 years..I feel great! FINALLY!.....My question is..Is there an update on Ibalizumb as of 2012? THE WAIT WAS WORTH IT! Ibalizumb, norvir, Trampavir (spelling), and Isentress...all new to me.... Thanks In Advance for your reply, East Texas

Response from Mr. Vergel

I am glad you were able to finally get your HIV in control. Ibalizumab has also been great for me. Like you, it took me a long time (26 years) to get to undetectable no matter what I did.

The company that makes ibalizumab is still looking for commercial partners to proceed with their phase 3 studies that will lead to the approval of the drug. They are also testing a subcutaneous version of the drug (the current form is dosed intravenously every two weeks).

We will hopefully know more about the status of this drug's development by summer.


Dr. not serious about helping me recover from HIV wasting
Guidelines for trainers

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint